497 related articles for article (PubMed ID: 15146581)
1. [Mercury in vaccines].
Hessel L
Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
[TBL] [Abstract][Full Text] [Related]
2. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
Clements CJ; McIntyre PB
Expert Opin Drug Saf; 2006 Jan; 5(1):17-29. PubMed ID: 16370953
[TBL] [Abstract][Full Text] [Related]
3. The evidence for the safety of thiomersal in newborn and infant vaccines.
Clements CJ
Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295
[TBL] [Abstract][Full Text] [Related]
4. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
Pichichero ME; Gentile A; Giglio N; Umido V; Clarkson T; Cernichiari E; Zareba G; Gotelli C; Gotelli M; Yan L; Treanor J
Pediatrics; 2008 Feb; 121(2):e208-14. PubMed ID: 18245396
[TBL] [Abstract][Full Text] [Related]
5. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(26):563-5. PubMed ID: 10418806
[TBL] [Abstract][Full Text] [Related]
6. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
Parker SK; Schwartz B; Todd J; Pickering LK
Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856
[TBL] [Abstract][Full Text] [Related]
7. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
Geier DA; Geier MR
Med Sci Monit; 2004 Mar; 10(3):PI33-9. PubMed ID: 14976450
[TBL] [Abstract][Full Text] [Related]
8. Thiomersal in vaccines: is removal warranted?
Clements CJ; Ball LK; Ball R; Pratt RD
Drug Saf; 2001; 24(8):567-74. PubMed ID: 11480489
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
Geier D; Geier MR
Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492
[TBL] [Abstract][Full Text] [Related]
10. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
[TBL] [Abstract][Full Text] [Related]
11. Thiomersal-containing vaccines - a review of the current state of knowledge.
Gołoś A; Lutyńska A
Przegl Epidemiol; 2015; 69(1):59-64, 157-61. PubMed ID: 25862449
[TBL] [Abstract][Full Text] [Related]
12. [Thiomersal and immunisations].
Weisser K; Bauer K; Volkers P; Keller-Stanislawski B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Dec; 47(12):1165-74. PubMed ID: 15583887
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States.
Geier DA; Geier MR
J Toxicol Environ Health A; 2006 Aug; 69(15):1481-95. PubMed ID: 16766480
[TBL] [Abstract][Full Text] [Related]
14. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
Heron J; Golding J;
Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
[TBL] [Abstract][Full Text] [Related]
15. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
Geier DA; Geier MR
Pediatr Rehabil; 2003; 6(2):97-102. PubMed ID: 14534046
[TBL] [Abstract][Full Text] [Related]
16. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study.
Pichichero ME; Cernichiari E; Lopreiato J; Treanor J
Lancet; 2002 Nov; 360(9347):1737-41. PubMed ID: 12480426
[TBL] [Abstract][Full Text] [Related]
17. Continuing increases in autism reported to California's developmental services system: mercury in retrograde.
Schechter R; Grether JK
Arch Gen Psychiatry; 2008 Jan; 65(1):19-24. PubMed ID: 18180424
[TBL] [Abstract][Full Text] [Related]
18. Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease.
Bigham M; Copes R
Drug Saf; 2005; 28(2):89-101. PubMed ID: 15691220
[TBL] [Abstract][Full Text] [Related]
19. An assessment of thimerosal use in childhood vaccines.
Ball LK; Ball R; Pratt RD
Pediatrics; 2001 May; 107(5):1147-54. PubMed ID: 11331700
[TBL] [Abstract][Full Text] [Related]
20. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
